Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.53)
# 865
Out of 5,152 analysts
96
Total ratings
40%
Success rate
8.84%
Average return
Main Sectors:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARCT Arcturus Therapeutics Holdings | Maintains: Overweight | $72 → $25 | $7.06 | +254.11% | 3 | Mar 4, 2026 | |
| CLYM Climb Bio | Initiates: Overweight | $23 | $7.00 | +228.57% | 1 | Feb 13, 2026 | |
| KRRO Korro Bio | Upgrades: Overweight | $11 → $30 | $10.64 | +181.95% | 3 | Jan 29, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Overweight | $450 → $1,200 | $313.50 | +282.78% | 4 | Jan 28, 2026 | |
| STTK Shattuck Labs | Initiates: Overweight | $15 | $5.64 | +165.96% | 1 | Jan 28, 2026 | |
| BIOA BioAge Labs | Initiates: Overweight | $73 | $20.52 | +255.75% | 1 | Jan 27, 2026 | |
| PALI Palisade Bio | Initiates: Overweight | $25 | $1.67 | +1,401.50% | 1 | Dec 29, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Overweight | $540 → $900 | $431.53 | +108.56% | 5 | Dec 19, 2025 | |
| ORKA Oruka Therapeutics | Initiates: Overweight | $75 | $32.37 | +131.70% | 1 | Dec 18, 2025 | |
| PRTA Prothena Corporation | Maintains: Overweight | $15 → $36 | $9.53 | +277.75% | 5 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $78 | $23.46 | +232.55% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $11.75 | +70.29% | 1 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $26 | $6.12 | +325.18% | 1 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $4 | $1.29 | +210.08% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $78 | $3.86 | +1,920.73% | 1 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $93 → $145 | $38.64 | +275.26% | 2 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 | $27.90 | +82.80% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $6 | $1.66 | +261.45% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $17.77 | +170.19% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $76.13 | +22.16% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $75 | $7.56 | +892.06% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $105 | $72.00 | +45.84% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $29.59 | +25.04% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $6.62 | +292.75% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $1.20 | +2,233.33% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $38.82 | +149.87% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $29.80 | +155.08% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $3.53 | +608.22% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $10.85 | +176.50% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $9.95 | +20.60% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $6.80 | +1,223.53% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $0.50 | +2,917.50% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $5.37 | +197.95% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $57.58 | +38.94% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $58.50 | +58.97% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $26.26 | +117.06% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $5.43 | +1,133.89% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $20 | $0.85 | +2,262.11% | 5 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $92.10 | -62.00% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $13.60 | +539.71% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $6.51 | +2,588.17% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $60.94 | +18.15% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $0.86 | +4,551.16% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.72 | +2,394.87% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $14.07 | +2,885.07% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $88.67 | -13.16% | 1 | Jul 31, 2020 |
Arcturus Therapeutics Holdings
Mar 4, 2026
Maintains: Overweight
Price Target: $72 → $25
Current: $7.06
Upside: +254.11%
Climb Bio
Feb 13, 2026
Initiates: Overweight
Price Target: $23
Current: $7.00
Upside: +228.57%
Korro Bio
Jan 29, 2026
Upgrades: Overweight
Price Target: $11 → $30
Current: $10.64
Upside: +181.95%
Praxis Precision Medicines
Jan 28, 2026
Maintains: Overweight
Price Target: $450 → $1,200
Current: $313.50
Upside: +282.78%
Shattuck Labs
Jan 28, 2026
Initiates: Overweight
Price Target: $15
Current: $5.64
Upside: +165.96%
BioAge Labs
Jan 27, 2026
Initiates: Overweight
Price Target: $73
Current: $20.52
Upside: +255.75%
Palisade Bio
Dec 29, 2025
Initiates: Overweight
Price Target: $25
Current: $1.67
Upside: +1,401.50%
Madrigal Pharmaceuticals
Dec 19, 2025
Maintains: Overweight
Price Target: $540 → $900
Current: $431.53
Upside: +108.56%
Oruka Therapeutics
Dec 18, 2025
Initiates: Overweight
Price Target: $75
Current: $32.37
Upside: +131.70%
Prothena Corporation
Oct 28, 2025
Maintains: Overweight
Price Target: $15 → $36
Current: $9.53
Upside: +277.75%
Oct 6, 2025
Initiates: Overweight
Price Target: $78
Current: $23.46
Upside: +232.55%
Sep 8, 2025
Initiates: Overweight
Price Target: $20
Current: $11.75
Upside: +70.29%
Aug 27, 2025
Initiates: Overweight
Price Target: $26
Current: $6.12
Upside: +325.18%
Aug 8, 2025
Maintains: Overweight
Price Target: $17 → $4
Current: $1.29
Upside: +210.08%
Jun 12, 2025
Initiates: Overweight
Price Target: $78
Current: $3.86
Upside: +1,920.73%
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $38.64
Upside: +275.26%
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $27.90
Upside: +82.80%
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $1.66
Upside: +261.45%
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $17.77
Upside: +170.19%
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $76.13
Upside: +22.16%
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $7.56
Upside: +892.06%
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $72.00
Upside: +45.84%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $29.59
Upside: +25.04%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $6.62
Upside: +292.75%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $1.20
Upside: +2,233.33%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $38.82
Upside: +149.87%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $29.80
Upside: +155.08%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $3.53
Upside: +608.22%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $10.85
Upside: +176.50%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $9.95
Upside: +20.60%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $6.80
Upside: +1,223.53%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $0.50
Upside: +2,917.50%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $5.37
Upside: +197.95%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $57.58
Upside: +38.94%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $58.50
Upside: +58.97%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $26.26
Upside: +117.06%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $5.43
Upside: +1,133.89%
Jul 21, 2023
Maintains: Overweight
Price Target: $13 → $20
Current: $0.85
Upside: +2,262.11%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $92.10
Upside: -62.00%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $13.60
Upside: +539.71%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $6.51
Upside: +2,588.17%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $60.94
Upside: +18.15%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $0.86
Upside: +4,551.16%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.72
Upside: +2,394.87%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $14.07
Upside: +2,885.07%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $88.67
Upside: -13.16%